Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip C Robinson

Showing results (31-40 of 148) with videos related to

Pageof 15
Sort By:
The Lancet. Rheumatology|August 22, 2022
Preventive medicine in rheumatology: COVID-19 and its lessons for better health outcomesDavid F L Liew, Philip C Robinson
Rheumatology and Therapy|February 22, 2019
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and TherapyPhilip C Robinson, Raj Sengupta, Stefan Siebert
Best Practice & Research. Clinical Rheumatology|February 21, 2021
Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic diseasePhilip C Robinson, Alfred H J Kim
Current Opinion in Rheumatology|July 18, 2020
Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseasesMilena Gianfrancesco, Jinoos Yazdany, Philip C Robinson
Arthritis Care & Research|June 20, 2020
Cost-Effectiveness of Colchicine Prophylaxis for Gout Flares When Commencing AllopurinolPhilip C Robinson, Nicola Dalbeth, Peter Donovan
Best Practice & Research. Clinical Rheumatology|January 20, 2021
Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomesRebecca Grainger, Pedro M Machado, Philip C Robinson
Rheumatology (Oxford, England)|June 14, 2015
Endoplasmic reticulum aminopeptidases in the pathogenesis of ankylosing spondylitisTony J Kenna, Philip C Robinson, Nigil Haroon
The Journal of Rheumatology|August 3, 2015
An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice PopulationPhilip C Robinson, William J Taylor, Nicola Dalbeth
Current Opinion in Rheumatology|January 4, 2021
Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology AlliancePhilip C Robinson, Jinoos Yazdany, Pedro M Machado
Microbial Drug Resistance (Larchmont, N.Y.)|June 21, 2014
Poor compliance with community-acquired pneumonia antibiotic guidelines in a large Australian private hospital emergency departmentHelen L Robinson, Philip C Robinson, Michael Whitby
Pageof 15

Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
The Lancet. Rheumatology|August 22, 2022
Preventive medicine in rheumatology: COVID-19 and its lessons for better health outcomesDavid F L Liew, Philip C Robinson
Rheumatology and Therapy|February 22, 2019
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and TherapyPhilip C Robinson, Raj Sengupta, Stefan Siebert
Best Practice & Research. Clinical Rheumatology|February 21, 2021
Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic diseasePhilip C Robinson, Alfred H J Kim
Current Opinion in Rheumatology|July 18, 2020
Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseasesMilena Gianfrancesco, Jinoos Yazdany, Philip C Robinson
Arthritis Care & Research|June 20, 2020
Cost-Effectiveness of Colchicine Prophylaxis for Gout Flares When Commencing AllopurinolPhilip C Robinson, Nicola Dalbeth, Peter Donovan
Best Practice & Research. Clinical Rheumatology|January 20, 2021
Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomesRebecca Grainger, Pedro M Machado, Philip C Robinson
Rheumatology (Oxford, England)|June 14, 2015
Endoplasmic reticulum aminopeptidases in the pathogenesis of ankylosing spondylitisTony J Kenna, Philip C Robinson, Nigil Haroon
The Journal of Rheumatology|August 3, 2015
An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice PopulationPhilip C Robinson, William J Taylor, Nicola Dalbeth
Current Opinion in Rheumatology|January 4, 2021
Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology AlliancePhilip C Robinson, Jinoos Yazdany, Pedro M Machado
Microbial Drug Resistance (Larchmont, N.Y.)|June 21, 2014
Poor compliance with community-acquired pneumonia antibiotic guidelines in a large Australian private hospital emergency departmentHelen L Robinson, Philip C Robinson, Michael Whitby
Pageof 15